In this article, we discuss the main aspects regarding the recognition of cell surface glycoconjugates and the immunomodulation of responses against the progression of certain pathologies, such as cancer and infectious diseases. In the first part, we talk about different aspects of glycoconjugates and delve deeper into the importance of N-glycans in cancer immunotherapy. Then, we describe two important lectin families that have been very well studied in the last 20 years. Examples include the sialic acid-binding immunoglobulin (Ig)-like lectins (siglecs), and galectins. Finally, we discuss a topic that needs to be better addressed in the field of glycoimmunology: the impact of oncofetal antigens on the cells of the immune system. New findings in this area are of great importance for advancement, especially in the field of oncology, since it is already known that cellular interactions mediated by carbohydrate–carbohydrate and/or carbohydrate proteins are able to modulate the progression of different types of cancer in events that compromise the functionality of the immune responses.
Skin aging, including photoaging, is primarily triggered by chronic exposure to solar radiation, which induces free radical formation, cellular deoxyribonucleic acid (DNA) damage, and structural skin alterations. Achillea millefolium L. (Asteraceae) is rich in phenolic compounds and alkamides, substances known for their antioxidant activity. This study aimed to develop and characterize a photoprotective phytocosmetic nanoemulsion containing crude root extract of A. millefolium. The extract exhibited a total phenolic content of 3.067 ± 1.911 µg GAE/mL, potent antioxidant activity (EC50 = 69.11 ± 8.899 µg/mL), moderate tyrosinase inhibition (19 ± 1.8%), and no cytotoxicity in keratinocytes. The extract was incorporated into nanoemulsions at concentrations of 0.1%, 0.5%, and 1%. The resulting droplets showed mean diameters of 217 to 230 nm, with a significant increase in the polydispersity index (PDI) after extract addition (p < 0.05). Transmission electron microscopy (TEM) confirmed the spherical morphology of the droplets. The in vitro sun protection factor (SPF) was 14 ± 0.9 in the control formulation and increased to 15 ± 2.0 (0.1%), 22 ± 5.2 (0.5%), and 17 ± 1.0 (1%), suggesting a synergistic effect between the extract and chemical filters. All formulations demonstrated UVA/UVB ratio > 0.6, a pH near to 5, occlusive properties, and good spreadability. The results indicate that A. millefolium extract holds potential for safe photoprotective formulations, offering a valuable antioxidant and depigmenting activity in addition to enhancing the SPF. This position is an innovative alternative to phytocosmetic development.
Cancer cells are characterized by metabolic reprogramming, which enables their survival in of-ten inhospitable conditions. A very well-documented example that has gained attraction in re-cent years and is already considered a hallmark of transformed cells is the reprogramming of carbohydrate metabolism. Such a feature, in association with the differential expression of en-zymes involved in the biosynthesis of glycoconjugates, generically known as glycosyltransfer-ases, contributes to the expression of structurally atypical glycans when compared to those ex-pressed in healthy tissues. The latest studies have demonstrated that glycophenotypic alterations are capable of modulating multifactorial events essential for the development and/or progres-sion of the disease. Herein, we will address the importance of glycobiology in modern medi-cine, focusing on the ability of unusual/truncated O-linked glycans to modulate two complex and essential phenomena for cancer progression: the acquisition of the multidrug resistance (MDR) phenotype and the activation of molecular pathways associated with the epithelial–mesenchymal transition (EMT) process, an event deeply linked with cancer metastasis.